一般肥満と中心性肥満における交差的格差:英国バイオバンク横断研究
Joseph Hutchinson1, Natalie Darko2, Rebecca Hardy3
1School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, UK. j.Hutchinson@lboro.ac.uk.
International journal of obesity (2005)
|January 6, 2026
まとめ
交差的格差は、ボディマス指数(BMI)と肥満に大きな影響を与えます。これらの剥奪と人口統計の組み合わせた影響を理解することは、効果的な健康政策にとって重要です。
科学分野:
- 公衆衛生;疫学;健康の社会的決定要因
背景:
- 個人および近隣の剥奪は交差し、健康に独自の影響を与える可能性がある。これらの複合的な剥奪が、人口統計全体における一般肥満と中心性肥満にどのように影響するかについての理解は限られている。
研究 の 目的:
- 個人および近隣の剥奪の交差的格差が肥満に及ぼす影響を調査する。これらの肥満関連格差における人口統計学的差異を分析する。
主な方法:
- 452,339人の参加者からの英国バイオバンクデータを利用した。収入、近隣の剥奪、性別、民族性、年齢に基づいて320の層に個人をグループ化した。BMI、脂肪量指数(FMI)、およびウエスト・トゥ・ハイト比(WHtR)の格差を評価するために多層分析を適用した。
主要な成果:
- 交差的格差は、総変動の6.5%(BMI)、25.2%(FMI)、および9.1%(WHtR)を説明した。交互作用効果は、この格差の最大26.5%を占めた。裕福な白人女性は有利であり、剥奪された黒人女性は不利に直面するという特定のパターンが特定された。男性は逆の関係を経験した。
結論:
- 肥満変動のかなりの部分が交差的格差に関連しており、有意な交互作用成分が存在する。政策介入は、失敗を防ぎ、ハイリスクグループを効果的にターゲットにするために、これらの交差的影響を考慮する必要がある。
関連する概念動画
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Bias in Epidemiological Studies
1.3K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.3K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
235
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
235
Drug Dosing: Obese Patients
217
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
217
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
165
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
165
Cholesterol: Significance and Regulation
1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.2K


